PureTech Health (PRTC) Competitors $20.28 -0.80 (-3.80%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends PRTC vs. APGE, IBRX, WVE, MIRM, AKRO, TARS, AMPH, IRON, CGON, and HRMYShould you be buying PureTech Health stock or one of its competitors? The main competitors of PureTech Health include Apogee Therapeutics (APGE), ImmunityBio (IBRX), Wave Life Sciences (WVE), Mirum Pharmaceuticals (MIRM), Akero Therapeutics (AKRO), Tarsus Pharmaceuticals (TARS), Amphastar Pharmaceuticals (AMPH), Disc Medicine (IRON), CG Oncology (CGON), and Harmony Biosciences (HRMY). These companies are all part of the "pharmaceutical products" industry. PureTech Health vs. Apogee Therapeutics ImmunityBio Wave Life Sciences Mirum Pharmaceuticals Akero Therapeutics Tarsus Pharmaceuticals Amphastar Pharmaceuticals Disc Medicine CG Oncology Harmony Biosciences PureTech Health (NASDAQ:PRTC) and Apogee Therapeutics (NASDAQ:APGE) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, profitability, valuation, dividends, earnings, analyst recommendations, institutional ownership, risk and community ranking. Do analysts recommend PRTC or APGE? PureTech Health presently has a consensus target price of $45.00, indicating a potential upside of 121.89%. Apogee Therapeutics has a consensus target price of $89.71, indicating a potential upside of 88.04%. Given PureTech Health's stronger consensus rating and higher possible upside, equities analysts plainly believe PureTech Health is more favorable than Apogee Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PureTech Health 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50Apogee Therapeutics 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has stronger valuation & earnings, PRTC or APGE? PureTech Health has higher revenue and earnings than Apogee Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPureTech Health$3.33M145.81-$65.70MN/AN/AApogee TherapeuticsN/AN/A-$83.99M-$2.42-19.71 Does the media favor PRTC or APGE? In the previous week, Apogee Therapeutics had 12 more articles in the media than PureTech Health. MarketBeat recorded 17 mentions for Apogee Therapeutics and 5 mentions for PureTech Health. Apogee Therapeutics' average media sentiment score of 0.90 beat PureTech Health's score of 0.69 indicating that Apogee Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PureTech Health 3 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Apogee Therapeutics 10 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community prefer PRTC or APGE? Apogee Therapeutics received 15 more outperform votes than PureTech Health when rated by MarketBeat users. Likewise, 100.00% of users gave Apogee Therapeutics an outperform vote while only 45.00% of users gave PureTech Health an outperform vote. CompanyUnderperformOutperformPureTech HealthOutperform Votes945.00% Underperform Votes1155.00% Apogee TherapeuticsOutperform Votes24100.00% Underperform VotesNo Votes Do insiders and institutionals have more ownership in PRTC or APGE? 0.0% of PureTech Health shares are owned by institutional investors. Comparatively, 79.0% of Apogee Therapeutics shares are owned by institutional investors. 5.3% of PureTech Health shares are owned by insiders. Comparatively, 36.1% of Apogee Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Which has more risk & volatility, PRTC or APGE? PureTech Health has a beta of 1.2, suggesting that its share price is 20% more volatile than the S&P 500. Comparatively, Apogee Therapeutics has a beta of 2.3, suggesting that its share price is 130% more volatile than the S&P 500. Is PRTC or APGE more profitable? PureTech Health's return on equity of 0.00% beat Apogee Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets PureTech HealthN/A N/A N/A Apogee Therapeutics N/A -21.81%-20.94% SummaryApogee Therapeutics beats PureTech Health on 8 of the 15 factors compared between the two stocks. Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now Get PureTech Health News Delivered to You Automatically Sign up to receive the latest news and ratings for PRTC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PRTC vs. The Competition Export to ExcelMetricPureTech HealthPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$485.54M$6.57B$5.02B$9.08BDividend YieldN/A3.09%4.87%4.20%P/E RatioN/A10.55135.0817.16Price / Sales145.81194.011,120.30115.67Price / CashN/A57.1640.5837.88Price / Book1.205.104.754.78Net Income-$65.70M$151.51M$118.50M$225.60M7 Day Performance-0.34%-2.13%-1.85%-1.21%1 Month Performance-6.89%-3.13%11.28%3.09%1 Year Performance8.86%11.54%29.91%16.48% PureTech Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PRTCPureTech Health1.9926 of 5 stars$20.28-3.8%$45.00+121.9%+3.8%$485.54M$3.33M0.00100Gap UpAPGEApogee Therapeutics2.6029 of 5 stars$46.91+5.4%$83.88+78.8%+92.5%$2.11BN/A-18.3991IBRXImmunityBio2.1347 of 5 stars$3.02+5.2%$17.38+475.3%-42.2%$2.10B$7.33M-3.36590Analyst ForecastWVEWave Life Sciences4.8814 of 5 stars$13.56+0.9%$22.22+63.9%+181.5%$2.07B$113.31M-12.11240Positive NewsMIRMMirum Pharmaceuticals4.0869 of 5 stars$42.36-0.2%$57.73+36.3%+34.8%$2.03B$307.03M-21.01140Positive NewsAKROAkero Therapeutics4.0795 of 5 stars$29.09+0.7%$46.83+61.0%+36.1%$2.03BN/A-7.7030Insider TradeTARSTarsus Pharmaceuticals0.3253 of 5 stars$51.76-1.4%$54.20+4.7%+164.4%$1.98B$17.45M-13.7850Positive NewsAMPHAmphastar Pharmaceuticals4.8572 of 5 stars$40.95-3.1%$60.33+47.3%-33.1%$1.97B$644.40M14.081,761IRONDisc Medicine3.3068 of 5 stars$66.04+1.8%$87.50+32.5%+13.2%$1.97BN/A-16.3078Insider TradeCGONCG Oncology2.1538 of 5 stars$28.59-0.6%$63.88+123.4%N/A$1.93B$684,000.000.0061Insider TradeHRMYHarmony Biosciences4.7837 of 5 stars$32.92+1.6%$47.00+42.8%+7.0%$1.88B$681.88M15.35200Analyst ForecastAnalyst Revision Related Companies and Tools Related Companies APGE Alternatives IBRX Alternatives WVE Alternatives MIRM Alternatives AKRO Alternatives TARS Alternatives AMPH Alternatives IRON Alternatives CGON Alternatives HRMY Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:PRTC) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PureTech Health plc Please log in to your account or sign up in order to add this asset to your watchlist. Share PureTech Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
